PolyTherics appoints new Chairman
PolyTherics Limited announced that Dr Ken Cunningham has been appointed Chairman. Dr Mike Hayes, the current Non-Executive Chairman, will continue as a Non-Executive Director.
Dr Cunningham has over 20 years’ experience in the pharmaceutical industry. He is currently Chief Executive Officer of SkyePharma, having joined the Company in 2006, initially as Chief Operating Officer. Previously, he was Chief Executive Officer of Arakis Ltd, Vice-President European Affairs at Alza Corporation and Vice-President Clinical Development at Sequus Inc. Prior to this he held a variety of clinical development and commercial strategy roles at GlaxoWellcome plc and, earlier in his career, was with Warner-Lambert. Dr Cunningham is a Non-Executive Director of Xention Ltd. He holds a medical degree from St Mary's, Imperial College, London University.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.